OS Therapies Incorporated (OSTX) analyst actions
Rating and price-target actions on OSTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the OSTX overview →
2 measured OSTX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms | Press release | +0.56% | -5.03% | |
| OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing | Press release | +6.43% | -19.50% |
Keep exploring
More OSTX: earnings → · SEC filings → · OSTX overview →